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Interpretable classification of Alzheimer’s disease
pathologies with a convolutional neural network
pipeline
Ziqi Tang 1,2, Kangway V. Chuang 1, Charles DeCarli3, Lee-Way Jin 4, Laurel Beckett 5,
Michael J. Keiser 1 & Brittany N. Dugger 6
Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated
morphologies. Standard semi-quantitative scoring approaches, however, are coarse-grained
and lack precise neuroanatomic localization. We report a proof-of-concept deep learning
pipeline that identifies specific neuropathologies—amyloid plaques and cerebral amyloid
angiopathy—in immunohistochemically-stained archival slides. Using automated segmenta-
tion of stained objects and a cloud-based interface, we annotate > 70,000 plaque candidates
from 43 whole slide images (WSIs) to train and evaluate convolutional neural networks.
Networks achieve strong plaque classification on a 10-WSI hold-out set (0.993 and 0.743
areas under the receiver operating characteristic and precision recall curve, respectively).
Prediction confidence maps visualize morphology distributions at high resolution. Resulting
network-derived amyloid beta (Aβ)-burden scores correlate well with established semi-
quantitative scores on a 30-WSI blinded hold-out. Finally, saliency mapping demonstrates
that networks learn patterns agreeing with accepted pathologic features. This scalable means
to augment a neuropathologist’s ability suggests a route to neuropathologic deep
phenotyping.
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Extracellular deposition of amyloid-beta (Aβ) plaques is apathological hallmark of Alzheimer’s disease (AD)1,2, acommon neurodegenerative disease. Aβ plaques have a
diverse range of morphologies and neuroanatomic distributions1.
The current consensus criteria for a neuropathological diagnosis
of AD3–5 incorporate protocols assessing plaque density and
distribution; some researchers have hypothesized that plaques
may be an initiating event in AD5,6. More precise measures of
plaque morphologies (such as cored, neuritic, and diffuse) can
serve as a basis for understanding disease progression and
pathophysiology, providing guidance and insight into disease
mechanisms2,7–10.
For neuropathologic diagnosis, established semi-quantitative
scales are used to assess plaque burden (Fig. 1a)4,8,11,12. The
standard semi-quantitative criteria put forth by the Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD) based
on the manual assessment of the highest density of neocortical
neuritic plaques4,13. Diffuse plaques, which may be the initial
morphological type of Aβ14,15, can account for over 50% of
plaque burden in preclinical cases but are not included in
CERAD16. Furthermore, data on anatomical location (i.e., Thal
amyloid phase) are based on the presence of plaques regardless of
type or density5. The potential for neuropathologic deep pheno-
typing efforts that account for anatomic location, diverse sources
of proteinopathy, and quantitative pathology densities motivates
the development of effective and scalable quantitative methods to
differentiate pathological subtypes17–19.
Existing quantitative methods, such as positive pixel count20
algorithms, typically rely on human-defined21 red-green-blue
(RGB) or hue-saturation-value (HSV) ranges (i.e., pixel color and
intensity) and are thus sensitive to batch differences or to the
variable effects of formalin fixation on tinctorial properties.
Manual counts or stereological22,23 methods can be tedious, dif-
ficult to score, and time-consuming. Consequently, studies using
limited-range scores or overall pathology burden3,8,13,24 are
powerful but have interrater variability,4,13 are difficult to adapt
to statistically meaningful disease-correlation analysis, or are
blind to selected locational vulnerability20. New methods intro-
ducing detailed and sensitive quantification of pathologies would
reduce the burden placed on pathologists, increase reliability, and
enable studies at a scale that is currently prohibitive.
Deep learning has transformed medical image analysis25,26.
Convolutional neural networks (CNNs) have achieved expert-
level performance in complex visual recognition tasks, including
the diagnosis of skin27 and breast28,29 cancers. These flexible
models learn to recognize intricate patterns directly from visual
data without the need for manually-defined image features or
expert-delineated templates, and can account for non-trivial
variations in image quality and color. In neuropathology, deep
learning approaches have been reported for the classification of
AD pathophysiology in magnetic resonance and positron-
emission tomography images30–33, and for relating gene expres-
sion to neuropathology datasets34.
We hypothesized deep learning methods could augment neu-
ropathological whole slide image (WSI) analysis35. Despite their
strong predictive power, deep learning models have been criti-
cized for their poor interpretability and reliance on massive
annotated datasets36. At the outset, we recognized these factors
represented significant challenges in the development of useful
tools for neuropathology. An approach tailored to neuropathol-
ogy would require (1) careful delineation of the machine learning
task; (2) construction of a curated image dataset with high-
resolution annotations by experts; and (3) extensive model
interpretability. As a proof of concept, we posited CNN models
could be employed for recognition and classification of Aβ
pathologies, especially plaques, with the downstream goal of
providing reliable, scalable, and interpretable measures based on
neuroanatomical location. To develop a useful tool to aid
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Fig. 1Ways of assessing neuropathologies in human tissues. a Current protocols for neuropathological assessment of WSIs typically rely on comparatively
coarse-grained semi-quantitative scoring such as CERAD4. b We report an automated computational approach to process entire digitized
immunohistochemical stained archival slides, leveraging convolutional neural networks for amyloid plaque classification and localization
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neuropathologists, we deemed it critical that predictive perfor-
mance should result from learning meaningful patterns within
the images37.
In this study, we present a pipeline for the neuropathological
analysis of Aβ pathologies in WSIs generated by digitizing glass
microscope slides of temporal gyri of the human brain (Fig. 1b).
We describe an end-to-end pipeline for image processing, a
custom web interface for rapid expert annotation, and training of
CNN models that result in high performance multi-task classifiers
capable of distinguishing Aβ pathologies in the form of cored
plaques, diffuse plaques, and cerebral amyloid angiopathy (CAA).
We demonstrate how prediction confidence maps visualize dis-
tributions as an interpretable and complementary means to
understand Aβ burden. Finally, we provide visual evidence that
these models are interpretable, using deep learning introspection
methods to show that trained models learn relevant features of
each of these Aβ pathology classes. To the best of our knowledge,
these studies constitute the first report of CNNs for Aβ pathology
analysis.
Results
A platform to rapidly annotate 77,000 plaque candidates.
CNNs operate most effectively when trained on datasets
exceeding tens of thousands of example images38. Indeed, we
found that 43 digitized glass microscope slides (WSIs, see Sup-
plementary Table 1 for case details) used in this study yielded
over 500,000 individual candidate objects of interest. We set out
to build a dataset of approximately 50,000 annotated images for
model training (Fig. 2, see Data Availability). Manual annotation
at this scale would have been a daunting task through conven-
tional, hand-drawn bounding boxes on a standard ~700 micron
visual field. Using open-source image analysis tools (see Meth-
ods), we developed an automated preprocessing procedure
(Fig. 2a and Supplementary Figs. 1, 2) to normalize slide color
and generate bounding boxes around all immunohistochemically
(IHC)-stained objects within WSIs. As the native resolution of a
WSI is too large (typically 50,000 by 50,000 pixels at ×20 mag-
nification) to use as the direct input for CNNs, we designed the
dataset to contain uniform 256 × 256 pixel tiles centered on
individual plaque candidates.
We created a simple web interface to rapidly annotate Aβ
pathology-candidate image tiles and deployed it on the Amazon
Web Services Elastic Beanstalk39 for reliability and scalability
(illustrated in Fig. 2c). An expert neuropathologist annotator used
unique credentials and a rapid keystroke-entry format to annotate
the tiles, which were stored in a standardized query language
(SQL) database (see Supplementary Fig. 3). Using this platform,
candidate images were annotated at rates up to 2500 tiles per
hour into three major categories—cored plaques, diffuse plaques,
or CAA. Additional categories such as not sure or flag denoted
uncertainty, image segmentation failures, or other special cases
(Supplementary Fig. 3). The dataset was then built in three phases
(Table 1). In Phase I, 55,001 images were expert-labeled using the
web application. The majority of candidate images were
annotated as diffuse plaque morphologies (84.8% of the
annotations), with cored plaques (2.2%) and CAAs (1.1%)
making up the minor classes (Table 2). Furthermore, of the
CAA annotated images, a second annotation step divided the
group into capillary (36.3%) and non-capillary (63.7%). As class
balance typically improves machine learning model performance,
we sought to enrich the minority classes in a second phase. We
trained an intermediate CNN to classify objects based on the
Phase I dataset, then used its predictions to prioritize an
additional set of 101,671 unprocessed tiles in favor of cored
plaques and CAAs for manual annotation (see Supplementary
Fig. 4). Thus in Phase II, an additional 11,029 tiles were
annotated, having been evaluated in rank-order of their predicted
likelihood to contain either of the minority-class plaques. In
Phase III, we annotated an additional 10,873 candidate tiles
extracted from a separate hold-out test set of 10 WSIs not in the
original 33-WSI collection, without any prioritization procedures.
We performed manual annotation using the web application for
all phases.
CNNs effectively discriminate among Aβ morphologies. We
trained CNNs to classify tiles as containing cored plaque, diffuse
plaque, and/or CAA. At ×20 magnification, a single 256 × 256
pixel tile (128 microns) could contain more than one object, so
we trained a multi-task CNNs for multi-label classification: CNNs
were asked to determine the presence or absence of all
morphologies in each tile. We combined the Phase I and Phase II
datasets, then randomly split the resulting 70,000 tiles (66,030
annotated and 3970 IHC-negative) into training (from 29 WSIs)
and validation (from 4 WSIs) sets, while stratifying by case (i.e.,
WSI source) to ensure that models generalize to new cases. A
search of CNN architectures identified a six-layer convolutional
architecture with two dense layers (Fig. 3a) with strong perfor-
mance. Using subsequent hyperparameter optimization we found
data augmentation40,41 and minority class oversampling42 train-
ing procedures (Supplementary Fig. 5, Methods) yielded a pro-
nounced performance boost. For completeness, we also
recapitulated the analyses without WSI color normalization, but
saw no substantive change in performance (Supplementary
Fig. 6).
The resulting CNN model trained on 61,370 example tiles
achieved validation set performance of 0.983 area under the
receiver operator characteristic (AUROC) (Supplementary Fig. 7a)
with an area under the precision-recall curve (AUPRC) of 0.845
(Supplementary Fig. 7b). On the strict hold-out (Phase III) test
set, the model likewise generalized well to unseen decedent cases
(AUROC= 0.993, AUPRC= 0.743, Fig. 4a, b). CAA prediction
performance was also strong on the validation set (Supplemen-
tary Fig. 7), but was omitted from the Phase-III test set
benchmarking in Fig. 4 because Phase III was derived from cases
that were predominantly lacking in CAA in those specific regions
(e.g., Supplementary Fig. 8). The overall classification accuracy
was 0.973 on the validation set and 0.987 on the hold-out test set
(Supplementary Tables 3–5). Notably, model performance was
achieved using fewer than 2000 training examples of each
minority class (cored plaques and CAAs). Representative accurate
(Fig. 3b) and misclassified (Fig. 3c) examples from the 10,873
hold-out set tests illustrate cases where the model succeeded or
went astray.
Performance improves nonlinearly with training example
count. To determine whether similar performance could be
achieved with fewer manual annotations, we performed two
retrospective studies to investigate the effect of training dataset
size. In the first study, we randomly selected subsets of the
61,370-example training dataset, maintaining stratification by
case (i.e., WSI source), and plotted model performance as a
function of the number of training examples (Fig. 4c). Each
random selection was repeated five times, and a fresh model
trained each time, for a total of 90 independently trained and
evaluated CNN models with identical architectures. All models
were benchmarked against the same hold-out (Phase III, as in
Fig. 4a, b) test set. As expected, model performance positively
tracked with the total number of training examples. Notably,
models trained on a 50% smaller training set size still achieved an
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Fig. 2 Creation of an annotated plaque and CAA dataset for machine learning. a Summary of the image processing pipeline, including color normalization,
IHC stain segmentation, and extraction of candidate objects (red boxes), followed by rapid expert annotation using a cloud-based web application.
b Examples of extracted cored plaques (top row), diffuse plaques (middle), and CAA (bottom) and their surrounding tissue area. Rectangles shown in red
bound the candidate object during the labeling process. Scale bar= 25 μm. c A custom web interface allows for the rapid annotation of plaques by mouse
or keystroke, with visualization of raw (without color adjustments) and normalized images, showing the object bounding boxes around which the tile is
automatically centered and cropped
Table 1 Summary of annotated object tile dataset by project phase
Phase Cored plaque Diffuse plaque CAA Total
Development phase I 1233 (2.24%) 46,650 (84.82%) 778 (1.14%) 55,001
Development phase II 1035 (9.38%) 7610 (69.00%) 1405 (12.74%) 11,029
Development total 2268 (3.43%) 54,260 (82.17%) 2183 (3.31%) 66,030
Test (phase III) 83 (0.76%) 10,234 (94.12%) 7 (0.06%) 10,873
Remaining unlisted percentages correspond to Not Sure or Flagged labels (see Methods)
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average AUROC above 0.99 and an AUPRC above 0.74, at
minimal loss to overall performance.
In the second study, we investigated model performance as a
function of the chronological dataset growth during the project,
where training examples were included in the order of original
expert annotation (Fig. 4d). Model performance at 15 expert-
hours fell short of model performance at 50% of dataset size
(Fig. 4c). Accordingly, the goal of this second study was to
determine whether annotation chronology played a role in CNN
training. As above, performance steadily increases as the
annotated dataset grows. However, performance trends between
the studies differed in two ways. Chronologically-trained models
did not converge in AUPRC performance as early as the
equivalent-sized random-subset-trained models benefitting from
later annotations did. Second, the chronology study shows a
distinct AUPRC boost in Phase II, illustrating the positive effect
of enriching for cored-plaque prevalence.
Prediction confidence maps show plaque localization. To
visualize the distribution and neuroanatomic location of Aβ
pathologies in a broader context, we applied a sliding window
approach43 to generate WSI heatmaps of predictions (Fig. 5).
These heatmaps plot the confidence and location of each pre-
diction by the CNN, which may then be visualized from the sub-
tile resolution (Fig. 5c) up to the full WSI view (Fig. 5a). By
progressively zooming in from larger anatomical views, the
visualization shifts from the broad distribution of plaques to their
detailed ×20 morphology. A single cored plaque can be dis-
tinguished from a dense region of neighboring diffuse plaques
(Fig. 5c). In this cohort, diffuse plaques are densely distributed
across the gray matter, whereas cored plaques are predominantly
located in deeper and lower cortical layers, in accordance with
known neuroanatomic distributions1. Furthermore, CAA pre-
dictions predominantly appear proximal to the cortical surface
where leptomeninges are present44, although predictions are
made independently of the surrounding field or broader neu-
roanatomic context. These maps highlight other locational
aspects of the plaques, such as their presence in the white matter
immediately beneath the gray matter45.
Classification performance does not vary by tissue landmark.
The CNNs perform classification (e.g., Fig. 4) directly on small
Table 2 Annotated object dataset distribution by class and model performance
Images Cored plaque Diffuse plaque CAA AUROC (cored) AUPRC (cored)
Train 61,370 2141 48,123 2227 0.993 0.981
Validation 8630 381 7487 126 0.983 0.845
Test 10,873 98 10,480 7 0.993 0.743
Output morphologies
Cored CAA
0.000.001.00
Dense (100)
Expert label
Predicted 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.81 0.930.99 0.95 0.97 0.93
– – – – – – – –Cored CoredCAA CAADiffuse Diffuse Diffuse
Expert label
Predicted 0.32 0.64 0.00 0.87 0.00 0.88 0.99 0.43 0.00 0.82 0.880.31 0.00 0.00 0.91
– – – – – – –– –Cored CAADiffuse DiffuseDiffuse Diffuse
Dense (512)
MaxPool2D
MaxPool2D
MaxPool2D
MaxPool2D
MaxPool2D
MaxPool2D
Conv2D (8 × 8 × 512)
Conv2D (16 × 16 × 256)
Conv2D (32 × 32 × 256)
Conv2D (64 × 64 × 128)
Conv2D (128 × 128 × 64)
Conv2D (256 × 256 × 64)
kernel = (3,3), stride = 1
Diffuse
Input image (256 × 256 × 3)
a b
c
Fig. 3 CNN models identify three Aβ deposit types in image tiles. a The optimized CNN model architecture contained six convolutional layers and two
dense layers, using exclusively 3 × 3 kernels and alternating max-pooling layers. b Examples of correct CNN predictions. The ground truth expert label row
indicates the pathologies that had been manually found within the tile image. The predicted row shows corresponding model confidences for cored plaque
(yellow arrow), diffuse plaque (red), and CAA (blue) classes (from left to right). Model predictions range from 0.00 to 1.00, where a higher score indicates
higher predicted confidence by the CNN for that plaque class (e.g., the 1.00 corresponds to 100% model confidence that a cored plaque is present in the
leftmost panel). c Examples of CNN predictions that do not agree with the expert manual annotation. Incorrect model predictions are indicated by light
orange backgrounds in the predicted column; green backgrounds correspond to correct predictions. Scale bar= 25 μm for all images
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anatomical areas (128 microns; green box in Fig. 6a). Human
experts typically assess larger fields of view such as ~700 microns
viewed at ×10 magnification when conducting semi-quantitative
plaque scoring. To visualize prediction performance in this con-
text, we also assessed cored-plaque agreement maps on con-
tiguous 6-by-6 tile (768 micron) regions (Fig. 6a). In the leftmost
column, a green box surrounds the cored plaque within the tile, as
labeled by a neuropathologist during the Phase-III dataset
annotation (Fig. 6a). The middle column overlays the prediction
map (as in Fig. 5c) onto the original IHC-stained image. Finally,
the rightmost column summarizes agreement between the expert
label and the prediction, with blue and cyan representing correct
prediction areas, while red and orange denote misclassification46.
For this analysis, we used a CNN prediction confidence threshold
of 0.90. A more permissive threshold would decrease false
negatives (red) at the cost of more false positives (orange).
Interestingly, this agreement-map highlights the limitations of
bounding-box annotations, such that the correct cored-plaque
prediction shown is nonetheless penalized by this view (red halo)
for accurately predicting the rounded boundaries of the actual
plaque instead of anticipating its square ground truth bounding-
box.
Stepping further out to regions of 3840 microns (Fig. 6b), these
maps (see Supplementary Fig. 9 for additional examples) visualize
the results plotted in Fig. 4, with the complementary addition of
tissue landmarks, prediction clustering, and neuroanatomic
localization. The model reliably rejects background tissue and
diffuse plaque deposits, while accurately identifying most cored
plaques. Model performance does not change based on the nearby
neuroanatomic architecture in these examples, although occa-
sional clusters of co-localized false-positive (orange) cored plaque
predictions can appear (e.g., Supplementary Fig. 9).
Introspection studies identify salient plaque features. To
investigate the CNN model’s internal logic, we performed two
studies to determine the importance of morphology features
contributing to accurate predictions (Fig. 7). In the first, we
applied guided gradient-weighted class activation mapping
(Guided Grad-CAM)47 to identify salient visual features
underlying the model’s predictions. Guided Grad-CAM follows
the CNN’s gradient flow from individual tasks back onto the
original image tile to establish an activation map, highlighting
the input features most relevant to each CNN prediction. Fig-
ure 7 shows Guided Grad-CAM (white features on black
background) on examples taken from cored plaque, diffuse
plaque, and CAA classes. Consistent with human expertise,
Guided Grad-CAM activation maps predominantly highlight
regions of the tiles corresponding to IHC-stained Aβ patholo-
gies. For instance, in Fig. 7a, the activation map for cored-
plaque prediction highlights a dense and compact Aβ center
(yellow arrow), whereas for the diffuse task the activation map
highlights the off-center diffuse object (red arrow). By contrast,
the CAA activation map highlights the periphery of the image,
much as CAA often forms a ring within vessels, although none
could be found. In Fig. 7b, the diffuse-task Guided Grad-CAM
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Fig. 4 Predictive performance on the held-out Phase-II test set (n= 10,873). a Receiver operator characteristic (ROC) and b Precision-recall curves (PRC)
for cored (magenta lines) and diffuse (blue lines) plaques. The blue star marks the best trade-off point where prediction confidence threshold equals 0.91.
c Summarized areas under the ROC and PRC (AUPRC and AUROC) of independently-trained CNNs (n= 5 per point) for the task of cored plaque
classification, as a function of training dataset size. Dataset was randomly subsetted at each point independent of the date of tile annotation. Error bars
represent s.d. d AUPRC and AUROC of CNNs for the same task of cored-plaque classification, as a function of chronological dataset growth by annotation
timestamp, over the course of the project, showing chronology-dependent dataset effects. Source data are provided as a Source Data file
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highlights ill-defined amorphous Aβ pathologies, while for the
cored and CAA tasks it focuses on punctate IHC staining and
potential microglia. The CAA activation map in Fig. 7c high-
lights ring structures (blue arrow) within the media of the
cortical vessel, consistent with CAA’s defining feature; while for
cored and diffuse tasks, Guided Grad-CAM highlights the
punctate deposit (red arrow) beneath the CAA. Lastly Fig. 7d,
which contains both a diffuse (red arrow) and a cored plaque
(yellow arrow), shows cored-task activation maps localizing to
the amyloid core, with broader feature activations for diffuse
and CAA tasks. Crucially, Guided Grad-CAM activation
mapping may highlight certain image features as salient because
they help determine that an object is not present in the image:
Despite strong localized activation for cored and diffuse maps
in Fig. 7c at the punctate deposit (red arrow), the CNN predicts
that neither plaque is present.
Whereas Guided Grad-CAM provides a fine-grained view of
feature salience, it does not differentiate features indicative of a
plaque from those that contradict its presence. To complement
the analysis, we performed a feature occlusion study48 on the
same examples. In this experiment, a small occlusion patch
(shown in Fig. 7a, black box) is systematically moved across the
image, and the model makes a prediction on the occluded image
at each increment. Blue-to-yellow-to-red colors indicate increas-
ing CNN prediction confidence from 0.0 to 1.0. Consequently,
color shifts in occlusion maps show which image features, when
occluded, change prediction confidence. When the patch occludes
an important feature such as the amyloid core of a cored plaque
(Fig. 7a, yellow arrow), the model fails to predict the object
correctly: cored-task confidence drops to zero (blue dot on red
background, yellow arrow). Occluding less cored-task-relevant
regions such as within the off-center diffuse stain (red arrow)
have little effect, indicated by the solid red coloring in the cored-
task’s confidence map for this area. Conversely, confidence maps
may also show where occlusion of a critical feature makes an
alternative class more likely. If the amyloid core in Fig. 7a is
occluded, diffuse plaque prediction becomes likely (signified by
yellow arrow).
Where more than one plaque occur within the same tile, the
two feature-importance studies differ. Guided Grad-CAM
activation maps identify salient pixels for plaque classes
independently, whereas occlusion maps highlight the interplay
of features among classes. For example, in occlusion maps,
occluding the leftmost plaque decreases diffuse-task confidence
(Fig. 7d, light blue region in the diffuse-task map, red arrow),
whereas the same prediction gains confidence (red region, yellow
arrow) when the cored plaque’s core is occluded. In the
corresponding Guided Grad-CAM activation maps for
the diffuse-task, however, features specific to the diffuse plaque
are predominant. Together, these complementary maps visualize
the features within images that motivate the CNN’s plaque
predictions.
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Fig. 5 Prediction confidence heatmaps for cored plaques, diffuse plaques, and CAA. a Whole slide overview visualization, revealing broad amyloid
distribution patterns. Scale bar= 3mm. b Higher magnification (×4) view of the blue-boxed region from panel a. Scale bar= 750 μm. c Higher
magnification (×20) view of the blue-boxed region from panel b. Green box marks cored plaque manual annotation. Scale bar= 150 μm. Confidence scales
for each panel were bottom-capped to aid visualization, such that only confidence scores≥ 0.8 are plotted, with yellow being the most confidence, and
purple the least. Approximate (hand-drawn) boundaries of gray versus white matter (dotted line) and tissue boundaries (solid lines) are overlaid for
reference
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CNN-based WSI scores correlate with semi-quantitative scores.
To compare with manual semi-quantitative approaches such as
Consortium to Establish a Registry for Alzheimer’s Disease
(CERAD), we developed a preliminary neural-network derived
score for Aβ pathologies at a global WSI level. For the CNN-based
score, we calculated a count of each predicted Aβ pathology across
an entire WSI by segmenting its prediction heatmap (e.g., Fig. 5a)
and normalizing the result by the tissue area of each slide (Sup-
plementary Fig. 10). The resulting CNN-based scores correlated
strongly across the total dataset of 62 WSIs (Supplementary
Tables 1 and 2) for which we had independently-collected semi-
quantitative, CERAD-like scores for each specific class on 62 of
the WSIs (Fig. 8 and Supplementary Table 6). CNN-based scores
for Aβ pathologies significantly differentiated WSIs by CERAD-
like categories (e.g., moderate versus frequent), especially for cored
plaques (Fig. 8a, second row). For instance, CNN-based WSI
scores between none versus frequent CERAD-like categories were
exponentially separated. To better assess generalization, we col-
lected a further set of 20 WSIs (Supplementary Table 2) with
corresponding CERAD scores that were blinded during analysis.
Combined with the 10 separate hold-out WSIs from Phase III, we
found this 30-WSI blinded hold-out set demonstrated strong
correlation between the automated and manual scoring approa-
ches, such that CNN-based scores significantly discriminated
existing semi-quantitative categories (Fig. 8b).
Discussion
We report a scalable, quantitative, and interpretable approach to
identify neuropathologies for three classes of Aβ pathologies,
motivated by the method’s downstream application to statistically
powerful correlative analyses and neuroanatomical localization of
AD pathologies. In practice, such deep-phenotyping techniques
will have limited utility if their underlying predictions cannot be
interpreted, critiqued, and refined by expert neuropathologist
supervision. Consequently, to establish the feasibility and lim-
itations of this approach, we considered multiple challenges when
adapting CNNs to WSIs of archival human brain samples49: (1)
WSIs are prohibitively large and can vary in color, necessitating a
preprocessing pipeline for their normalization, segmentation, and
efficient annotation; (2) deep neural networks are notoriously
data-hungry; we evaluated how much training data a CNN
requires to discriminate Aβ morphologies (cored plaque, diffuse
plaque, and CAA); and (3) it is rarely obvious how generalizable a
model will be across diverse individuals, populations, and con-
ditions—to prove an enabling tool, model predictions must be
interpretable and derive from meaningful features amenable to a
neuropathologist’s critique and feedback.
Addressing the first challenge, we developed an end-to-end
pipeline to automate WSI processing and aid rapid image
annotation (Fig. 2a, Supplementary Fig. 3). This pipeline per-
forms color normalization50 followed by IHC stain detection to
create a preliminary library of candidate plaques at ×20 magni-
fication. The logic behind stain detection was two-part: Stained
objects inhabit a delimited brown hue range and objects comprise
coherent contiguous regions exceeding a minimum size. We then
generated image tiles centered on each candidate (Fig. 2b). Thus,
43 WSIs containing Aβ IHC-stained temporal gyri yielded nearly
500,000 raw candidate tiles at ×20 resolution (details in
Expert labels (cored only)
Equivalent visualizations in a field that is five times larger than (a)
At a cutoff of >= 0.9
0.8 1.0Confidence scale
At a cutoff of >= 0.9
0.8 1.0Confidence scale
Blind prediction heatmap Assessment of agreement
True positive
False positive
True negative
False negative
a
b
Fig. 6 Visualization of a representative example from the cored-plaque classification tests plotted in Fig. 4. a CNN model prediction confidence maps
(middle panel, as in Fig. 5c) overlaid onto the original slide tile. Bounding boxes mark cored-plaque expert annotations (left panel, green box). The
combined map (right panel) assesses agreement between the model’s predictions and the expert labels, where pixels are colored by a semi-transparent
overlay as true positive (blue), false positive (orange), true negative (cyan), and false negative (red) areas. Scale bar= 150 μm. b Prediction-versus-
annotation agreement map generated as in a, but with a larger field for greater tissue and plaque clustering context. Scale bar= 750 μm. Confidence scales
for middle panel are bottom-capped to aid visualization, such that only confidence scores≥ 0.8 are plotted, with yellow being the most confident and
purple the least
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Supplementary Table 1), filtered to approximately 200,000 tiles
containing candidate objects of sufficient size (see Methods). The
next step was image annotation for supervised machine learning.
Although web-based histopathological annotation tools exist51,52,
we developed a simple platform using the cloud-based Amazon
Web Services Elastic Beanstalk39 infrastructure (Supplementary
Fig. 3) for study design flexibility and for the speed of its
keystroke-based entry format. For instance, subsequent studies
may investigate a broader field of view for annotation context or
introduce checks on intra-rater reliability by re-presenting tiles to
annotators in different orientations. Given the scope of the
annotation task, we incorporated several aspects of gamification
theory53,54, such as annotator leveling, achievement badges, and
progress-bar filling55,56 to acknowledge and motivate progress.
Using this tool, we observed sustained annotation rates reaching
1.44 s per tile.
The second challenge was in determining the necessary train-
ing dataset size. Having manually annotated 66,030 candidate
tiles from 33 WSIs in two annotation phases (Table 1), plus 3970
randomly selected IHC-negative tiles, we examined the CNN’s
ability to precisely discriminate plaque and CAA morphologies.
For this analysis, we randomly split the tiles into train and vali-
dation sets, such that train and validation tiles never shared the
same WSI source. In addition, as a strict hold-out test set (Phase
III) and to investigate the role of nearby neuroanatomic land-
marks on prediction, we annotated larger contiguous tissue
regions corresponding to 5× the standard dimensions, for 10
previously unseen WSIs (Supplementary Fig. 8). Note this Phase
III dataset differed from the Phase I+ II train and validation
datasets in that the latter’s 70,000 labeled tiles were randomly
selected; there was no guarantee that tiles and their resulting
expert plaque annotations would be contiguous or comprehen-
sively labeled for any local region of tissue. We trained multi-task
CNNs on all 61,370 training tiles, evaluated multiple CNN
architectures and hyperparameter choices, and found that a
relatively simple model design (Fig. 3a) inspired by Simonyan and
Zisserman’s VGG57 achieved strong classification performance
(Fig. 4a, b).
Given the substantial time investment, we asked whether
similar performance could have been achieved with fewer training
tiles. We evaluated this retrospectively, by progressively
decreasing the training dataset size in two different ways (Fig. 4c,
d). In the first study, we selected a progression of training data
subsets randomly and repeated the training process five times per
subset size (Fig. 4c). In the second study, we maintained the
chronology of the project instead, and plot a natural history of the
annotation process. Intriguingly, these performance evaluations
highlighted two annotation regimes (Fig. 4d); first, unbiased
random-tile candidate labeling (Phase I), followed by the Phase II
procedure, where cored-plaque and CAA candidates were pur-
posefully enriched by bootstrapping from a Phase-I-trained CNN
model. As expected, increasing training example counts improved
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Fig. 7 Model interpretability studies using machine-learning introspection techniques. a A cored plaque example (top row, yellow arrow). For the task of
cored-plaque prediction, the activation map (by Guided Grad-CAM; left, second row) and the feature occlusion map (right, second row) identify the
amyloid core (yellow arrow) as the defining morphological feature. By contrast, the diffuse stained region (red arrow) only arises as a salient feature during
diffuse-plaque and CAA prediction tasks (third and fourth rows, respectively). b Diffuse plaque example where activation and feature occlusion maps focus
on ill-defined amorphous amyloid contours for diffuse-plaque classification task (third row). c CAA example, where the CAA task’s activation and feature
occlusion maps (fourth row) highlight amyloid ring pixels within the media of the cortical vessel (blue arrow), while for cored and diffuse tasks the small
punctate IHC staining is considered salient (red arrow; second and third rows). d Example containing both diffuse (red arrow) and cored (yellow arrow)
plaques in the same tile illustrate the difference between activation and feature occlusion maps. Confidence scales for feature occlusion maps represent the
CNN’s prediction confidence on the occluded image, with red being the most confident and blue the least. Scale bar= 25 μm
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model performance. Less anticipated was that chronologically-
early annotations appeared to be less effective for model training
(Fig. 4d); considerations such as the neuropathologist’s growing
familiarity with the annotation tool and its visual field may be
subjects for further study. From a practical perspective, the
steepest performance gains were achieved within the first 15 h of
expert labeling, suggesting a reduced dataset may be pragmati-
cally sufficient for classification of cored and diffuse plaques.
Significantly, models trained using a comparatively small invest-
ment of a neuropathologist’s time can assist with new cases and
Correlation between CNN-based and CERAD-like manual scoring. Entire dataset of 62 WSIs
Combined blinded hold-out sets of 30 WSIs
0.25
CN
N-
ba
se
d 
sc
or
es
 (c
ore
d p
laq
ue
)
0.20
0.15
0.10
0.05
0.00
CN
N-
ba
se
d 
sc
or
es
 (c
ore
d p
laq
ue
) 0.20
0.15
0.10
0.05
0.00
0.25
0.20
0.04
0.03
0.02
0.01
0.00
1.2
n.s. n.s.
CN
N-
ba
se
d 
sc
or
es
 (d
iffu
se
 pl
aq
ue
)
CN
N-
ba
se
d 
sc
or
es
 (C
AA
)1.0
0.8
0.6
0.4
0.2
0.0
0.035
0.030
0.025
0.020
0.015
0.010
0.005
0.000
1.2
CN
N-
ba
se
d 
sc
or
es
 (d
iffu
se
 pl
aq
ue
)
CN
N-
ba
se
d 
sc
or
es
 (C
AA
)
1.0
0.8
0.6
0.4
0.2
0.0
None
14
19
23
6
7
18
31
13
39
4
6
6
*** *** ** * ** ** *
Sparse
Sparse 0.00026
0.00011
0.0017
3e–11
7.8e–069.3e–10
Moderate
Moderate
Frequent
None Sparse Moderate
Frequent
CERAD-like categories (cored plaque)
t-test p-values
0.086
0.012
0.0016
0.0086
2.3e–052.8e–05
None Sparse Moderate
Sparse 0.0022
0.011
0.345
6.9e–08
0.0317.3e–05
Moderate
None Sparse Moderate
Frequent
p 
va
lu
es
< 1e–4
0.01
0.05
1
p 
va
lu
es
< 1e–4
0.01
0.05
1
p 
va
lu
es
< 1e–4
0.01
0.05
1
t-test p-values t -test p-values
Sparse 0.0072
0.0045
0.245
6.1e–06
0.010.00017
Moderate
None Sparse Moderate
Frequent
t-test p-values
Sparse 0.297
0.04
0.02
0.083
0.000330.0034
Moderate
None Sparse Moderate
Frequent
Sparse 0.269
0.0016
0.301
0.0001
0.00576.6e–07
Moderate
None Sparse Moderate
Frequent
p 
va
lu
es
< 1e–4
0.01
0.05
1
p 
va
lu
es
< 1e–4
0.01
0.05
1
p 
va
lu
es
< 1e–4
0.01
0.05
1
t-test p-values t -test p-values
None Sparse Moderate Frequent None Sparse Moderate Frequent
CERAD-like categories (diffuse plaque) CERAD-like categories (CAA)
None Sparse Moderate Frequent
CERAD-like categories (cored plaque)
None Sparse Moderate Frequent None Sparse Moderate Frequent
CERAD-like categories (diffuse plaque) CERAD-like categories (CAA)
8
6
13
7
17 3
2
6
19
4
2
3
n.s. n.s. n.s. n.s.
** ** * ***
a
b
Sparse
Moderate
Frequent
Fig. 8 Comparison of CNN-based Aβ-burden scores versus manual CERAD-like semi-quantitative scores at a whole-slide level for each pathology. a The
automatic and manual scores correlate well across the entire dataset of 62 independent WSIs, comprising the original Phase I-III slide set plus 20
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potentially reduce overall expert burden. Subsequent refinements
to the model, particularly in reinforcement feedback on
incorrectly-classified examples encountered during the model’s
use (e.g., Fig. 3d), might later be incorporated into the workflow
with minimal friction.
The third challenge was human interpretability. We posited
that visualizing the CNN model’s predictions as comprehensive
confidence maps from the whole-slide level down to a focused
plaque-level field (20×) would aid interpretability by a trained
neuropathologist, given the importance of local tissue and neu-
roanatomic context. On a neuroanatomic level, most predicted
plaques are located within gray matter (Fig. 5a, yellow-to-green
regions, right three columns) with some sparse densities in the
white matter not appreciated from the raw slide (Fig. 5a, left
column). Despite their primary localization within gray matter,
studies have reported plaques within white matter1,45,58. Fur-
thermore, the maps predict cored plaques’ propensity for deeper
and lower cortical layers, consistent with their known neuroa-
natomic distribution1,59. We were likewise gratified to observe
that individual cored plaques stand out from dense neighbor-
hoods of diffuse plaques (Fig. 5c, cored column) and that CAA
predictions made by the model on a 20 × (128 microns) tile-by-
tile basis nevertheless localized predominantly to the leptome-
ninges and some within cortex gray matter. There were caveats,
however, when clusters of diffuse plaques having staining halos
were misclassified as CAAs (Fig. 5b, CAA column). This was not
entirely surprising as the project focused on cored plaques, so the
CAA dataset was comparatively small; a larger CAA dataset
containing the full spectrum of its morphologies may be a useful
subject of further projects. Indeed, CAAs can be delineated into
various staging schemes, such as by their location within the
media of the vessel and vessel integrity11, which is important in
diagnosing CAA-related hemorrhage.
Using Phase III’s larger field-of-view (3840 microns) hold-out
regions, the overlays of CNN prediction confidence maps onto
ground-truth annotations highlighted cases and context of pre-
diction success and disagreement (Fig. 6b, Supplementary Fig. 9).
Nonetheless, accurate predictions alone do not guarantee mean-
ingful learning or that the model will be applicable to new sce-
narios or populations60. Plaque morphology can differ by
neuroanatomic location—a CNN model developed from tem-
poral gyri plaques may not be translatable to plaques in other
anatomic areas, such as the striatum1,61. Although an explicit
evaluation of all confounders is outside the scope of this work, the
feature saliency and occlusion map studies (Fig. 7) demonstrated
that the models focus on image features relevant for neuro-
pathology. Guided Grad-CAM techniques near-exclusively high-
lighted the IHC stained regions, in patterns characteristic of the
pathologies (Fig. 7, white-on-black maps). Complementarily,
feature occlusion studies illustrated that the central amyloid core
is the most discerning feature of a cored plaque’s correct identi-
fication, and that its occlusion transforms a CNN model’s clas-
sification to diffuse plaque. Importantly, the crucial features
emerging from these machine learning introspection techniques
—dense compact Aβ centers for cored plaques, ill-defined
amorphous Aβ deposits for diffuse plaques, and Aβ within the
media of the cortical vessels for CAAs—all agree with key features
used by experts1,11,62,63.
We finally evaluated whether CNN models could automatically
quantify Aβ burden on a whole-slide level in a way that would
correlate with standard semi-quantitative methods for plaque
assessment (i.e., CERAD neuritic plaque scores). As true neuritic
plaques are not distinguishable using Aβ-selective IHC stains, we
leveraged CERAD-like manual scores (none, sparse, moderate
and frequent) specific to each amyloid class. We found that a
preliminary WSI-level CNN-based score we developed (Methods)
correlated strongly with manual CERAD-like scores (Fig. 8).
CNN-based scores from one CERAD-like category were sig-
nificantly different from WSIs in other categories (for cored
plaque, p < 0.01, using two-sided Student’s t-tests). Beyond its
overall correspondence with CERAD, the finer-grained CNN-
based metric captured subtle variations of Aβ burden within each
CERAD category. The more detailed and sensitive measurement
of Aβ burden, after appropriate validation in further studies, may
strengthen statistical power for clinicopathological correlations64.
Automated scores of this nature might be applied across entire
archives of stained tissue from diverse anatomic regions, or aid in
studies focused on evaluating burden specific to certain neuroa-
natomic locales or other local landmarks.
Several caveats, however, merit mention. Foremost among
them is the intentional restriction of this proof-of-concept study’s
scope to annotations made by a single expert neuropathologist on
a single immunohistochemical stain within a single anatomic
region. Differences in experience and annotation criteria will
likely result in individual expert variation among ground truth
labels. The goal and intent of this project were therefore to
establish the potential to extend an individual neuropathologist’s
plaque-identification capabilities in the context of their normal
workflow. Furthermore, all data used in this study were from a
single brain bank and retrieved and digitized under the same
conditions; more diverse datasets from multiple sources will yield
more robust and reliable models. We noted also that when the
same hold-out set (Phase III) was annotated by web platform
(Fig. 2c) versus entirely by hand, this resulted in at times differing
labels (Supplementary Fig. 11). Future work may build on these
foundations to investigate cross-neuropathologist plaque labeling,
differing stains, anatomic regions, or collection centers, as well as
region-level scoring systems to quantify bulk Aβ pathology
burdens.
Taken together, the present study demonstrates a deep learning
approach that can augment the expertize and analysis of an
expert neuropathologist. Approximately 30 h of expert labeling
yield a highly scalable and reusable CNN model capable of novel
inference on unseen WSIs—going forward, 15 h may be sufficient
to create new visualizations and understandings of Aβ pathology
distribution. CNNs automatically learn relevant features from
immunohistochemical image data and to exploit Alzheimer’s
disease pathological features in agreement with human-
interpretable neuropathology. Significantly, CNN-based Aβ
pathology burden agrees with CERAD-like scoring. Many brain
banks have archival materials of stained slides arising from
neuropathological diagnosis; models such as these may capitalize
on such materials to help quantify pathologies providing patho-
logical deep phenotyping in a scalable way. We anticipate col-
lecting annotated datasets from multiple sources and experts will
improve recall, sensitivity, and accuracy of the resulting neural
network models and support training of more sophisticated
model architectures. We hope this proof of concept motivates
further work in this field, where automated pathology classifica-
tion could have far-reaching impact; to this end, we make the
CNN model code and dataset openly available to the community
(see Data Availability).
Methods
Ethics approval and consent to participate. These studies utilized only human
post-mortem tissues. Only living subjects are defined as Human Subjects under
federal law (45 CFR 46, Protection of Human Subjects). All participants or legal
representative signed informed consent during the life of the participant as part of
the University of California Davis Alzheimer’s Disease Center program. All human
subject involvement was overseen and approved by the Institutional Review Board
(IRB) at the University of California, Davis. All data followed current laws, reg-
ulations, and IRB guidelines (such as sharing de-identified data that does not
contain information used to establish the identity of individual deceased subjects).
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De-identified data do not contain personal health information (PHI) like names,
social security numbers, addresses, and phone numbers. Data were shared with a
randomly generated pseudo-identification number.
Case cohort. All samples were retrieved from archives of the University of Cali-
fornia, Davis Alzheimer’s Disease Center (UCD-ADC) Brain Bank. Archival
samples analyzed in this study were 5 μm formalin fixed, paraffin embedded,
sections of the superior and middle temporal gyrus. The tissue had been previously
stained with an Aβ antibody (4G8, recognizing residues 17–24, dilution 1:1600,
BioLegend (formally Covance), catalog number SIG-39200) that were first pre-
treated with formic acid to rid samples of endogenous protein. All slides were
digitized using an Aperio AT2 up to ×40 magnification. Supplementary Table 1
details overall NIA Reagan criteria65, CAA type66 1 or 2 within the section, and
Thal Amyloid phase5 of these cases.
Procedures were in accordance with ethical standards of the Helsinki
Declaration. Operations of the University of California Davis Alzheimer’s Disease
Center was approved by the Institutional Review Board (IRB) of the University of
California Davis, and written consent for autopsy was obtained for each participant
during life. Details of this program have been previously published67.
Dataset splitting. A total of 33 WSIs corresponding to 33 separate decedent cases,
spanning all clinicopathologically-assigned NIA Reagan criteria, and possessing a
variety of CERAD scores (see Supplementary Table 1) were used for model
development and training (29 training, 4 validation images). An additional 10
WSIs were selected by an expert neuropathologist (BD) as a held-out test set and
were not released until the model development phase of the study had been
completed. Finally, a further 20 blinded WSIs were collected solely for use in the
CERAD-like scoring comparison study and combined with the 10 test WSIs for the
30-WSI analysis reported in Fig. 8b. CERAD-like scores were available for all but
one of the 63 WSIs used in this study; thus Fig. 8a uses 62 WSIs as a complete
dataset.
Image preprocessing. All initial image preprocessing was performed in the open-
source library PyVips68. Images were loaded at ×20 magnification, corresponding
to a resolution of 0.5 microns per pixel (MPP). Slide color normalization was
performed by the method of Reinhard et al.69 using a reference image selected by
the annotating expert (see Supplementary Fig. 1). The resulting WSIs were reg-
ularly tiled to 1536 × 1536 pixel tiles, corresponding to 768 × 768 micron regions of
tissue for further analysis, resulting in a total of 33,111 tiles for the training set.
Image segmentation. Image segmentation was performed using the open-source
library OpenCV70. Immunohistochemically-stained entities including cored pla-
ques, diffuse plaques, and CAA appeared in the brown hue-region and segmen-
tation was performed in the HSV colorspace utilizing a permissive colormask. For
expert annotation, intracellular amyloid precursor protein (as denoted by cyto-
plasmic staining) was considered negative. Morphological opening and closing
operations were performed to smooth the binary masks, and a standard blob-
detection procedure was applied to isolate candidate objects. These unique com-
ponents were center-cropped to a fixed size (256 × 256 pixels), corresponding to a
region of 128 × 128 microns. This procedure resulted in nearly 500,000 images.
Noisy background deposits were eliminated through a minimum stained area
threshold of 1500 pixels (375 square microns), resulting in a total of 206,888 tiles.
Plaque-labeling web interface. To allow for the rapid and efficient annotation of
the dataset, we developed a custom Python Flask web application that we deployed
on Amazon Web Services Elastic Beanstalk39. The web-based interface allowed for
remote login by the expert labeler, and enables fast, multi-label annotation of
images using individual keystrokes. In the interface, images corresponding to 128 ×
128 microns regions were shown to the annotator. A bounding box in the image
specified which specific candidate object was to be labeled. Several elements of
gamification, such as leveling, achievement badges (crown icon), and progress bar
filling (green bar) were incorporated to motivate and track annotation task pro-
gress. A timestamp function was implemented to record the number of images per
hour annotated by the expert (BD). All labels were stored in a SQL database using
the Amazon Relational Database Service.
All images were annotated by a single neuropathologist (BD) and labeling of the
image data proceeded in three phases: (1) In an initial phase, 55,000 images
stemming from 3811 unique tiles were labeled; (2) In the second phase, images
containing the minor classes of interest (cored plaques and CAAs) were enriched
by running the CNN model built from the first-phase dataset on the remaining
101,671 images. These images were ranked by their predicted likelihood of
containing cored plaques or CAA. We then chose the top 11,029 images for
labeling. The labeled data from Phase I and Phase II were combined as the entire
dataset (Phase I+ II) for model training and evaluation. (3) In the third phase, two
test sets were constructed with the same data but two distinct labeling methods. A
7680 × 7680 pixel (0.5 MPP) region was selected within each of the 10 hold-out test
set WSIs by an expert neuropathologist as the area of interest. For the first test set,
10,873 candidate object tiles extracted from these 10 regions were labeled using the
image-labeling web interface. For the second test set, the cored plaques and CAA
were directly marked by a neuropathologist on the selected region at a standard
10 × (768 microns) visual field.
Model development and training. All neural network models were trained in the
open-source package PyTorch71 on four NVIDIA GTX 1080 or Titan X graphics
processing units. Our optimized model used a simple convolutional architecture for
image classification, consisting of alternating (3 × 3) kernels of stride 1 and padding
1 followed by max pooling (Fig. 3a), followed by two fully connected hidden layers
(512 and 100 neurons) and rectified linear units as the nonlinear activation
function. All neural network models were trained using backpropagation. The
optimized training procedure used the Adam72 optimizer with a multi-label soft
margin loss function with weight decay (L2 penalty, 0.008) and dropout (prob-
ability 0.5 for the first two fully connected layers and probability 0.2 for all con-
volutional layers). Training proceeded with mini-batches of 64 images with real-
time data augmentation including random flips, rotations, zoom, shear, and color
jitter. When calculating the classification accuracy, a threshold of 0.91, 0.1, and 0.85
was used for cored plaque, diffuse plaque, and CAA prediction, respectively.
Predictions with confidence above the threshold were considered to be positives.
Prediction confidence heatmaps. A sliding window approach43 was applied with
the trained CNN model to generate confidence heatmaps. At each step, the CNN
model took a 256 × 256 pixel region as input and generated a prediction score for
cored plaques, diffuse plaques, and CAAs. By systematically sliding the input
region across the entire image, the prediction scores were plotted as prediction
confidence heatmaps. The color represented the CNN’s prediction confidence for
the presence of cored plaques, diffuse plaques, and CAAs in the corresponding
region, with yellow being the most confidence, and purple the least. We used a
stride of 16, 4, and 1 for Fig. 5a–c, respectively.
Guided gradient-weight class activation maps. Guided gradient-weighted class
activation mapping (Guided Grad-CAM)47 was performed in PyTorch to generate
saliency maps that highlight relevant features on the class of interest. The saliency
map is a pointwise multiplication of guided backpropagation and Grad-CAM.
Guided backpropagation produces a pixel-space gradient map of predicted class
scores with respect to pixel intensities of the input image. Guided Grad-CAM
produces a more class specific map which is the dot product of the feature map of
the last convolutional layer and the partial derivatives of predicted class scores with
respect to the neurons in the last convolutional layer. We employed an open-source
implementation of Guided Grad-CAM by Ozbulak73 along with our trained
models to evaluate the learned features of the model on individual class examples
(Fig. 7).
Feature occlusion studies. Feature occlusion studies48 were performed to show
the influence of occluding regions of the input image to the confidence score
predicted by the CNN model. The occlusion map was computed by replacing a
16 × 16 pixels region of the image with a pure white patch and generating a
prediction on the occluded image. As systematically sliding the white patch across
the whole image (stride= 1 pixel), the prediction score on the occluded image was
recorded as an individual pixel of the corresponding occlusion map. The color
represented the CNN’s prediction confidence for the presence of cored plaques,
diffuse plaques, and CAAs of the occluded image, with red being the most con-
fidence, and blue the least.
Segmentation on prediction heatmaps and CNN-based scoring. Prediction
confidence heatmaps were segmented using the open-source library OpenCV70.
First, a CNN confidence threshold was applied to the heatmaps, with only pre-
diction confidences higher than the threshold retained, indicating the positive
predictions of plaques. Morphological opening and closing operations were then
performed to smooth the binary masks, and prediction areas exceeding a second
threshold set to eliminate CNN-noise. Application of a standard blob-detection
algorithm predicted discrete counts of the Aβ pathologies by the CNN model,
which were then normalized by tissue area to provide CERAD-like scores. These
hyperparameters, CNN confidence threshold (cored plaque: 0.1; diffuse plaque:
0.95; CAA: 0.9) and size threshold (cored plaque: 100; diffuse plaque: 1; CAA: 200
pixels), were optimized by statistical analysis on the training and validation sets.
Tissue segmentation. Tissue areas from WSIs were calculated using the open-
source libraries PyVips and OpenCV. Tissue segmentation against the slide
background was performed by applying a color mask in the lightness-chroma-hue
(LCH) colorspace. Morphological opening and closing operations were performed
to smooth the binary mask, and the tissue areas were calculated as the pixel sum of
the refined mask.
Statistical analyses. Statistical analyses were performed using the open-source
library SciPy (http://www.scipy.org/). Spearman rank-order correlation coefficient
was calculated between CNN-derived scores and CERAD categories for the
superior and middle temporal gyrus. A two-sided Student’s t-test was used to test
the null hypothesis that two independent samples have identical expected values.
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CNN scores of WSIs from different CERAD categories were used for the test. Data
were presented as box plots overlaid with individual data points. Box plots showed
interquartile range (top and bottom of the box), median (central band), and out-
liers (points beyond the whiskers). Individual data points were shown as specific
points. p ≥ 0.05 was considered not significant (ns); *p < 0.05, **p < 0.01, ***p <
0.001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
We have made the full raw WSI dataset and the annotated plaque-level dataset (https://
doi.org/10.5281/zenodo.1470797) openly available. A landing page is available at https://
www.keiserlab.org/resources. The source data underlying Figs. 4a–d and 8a–d and
Supplementary Figs. 6a–d and 7a, b are provided as a Source Data file.
Code availability
Source code for the CNN model is available at https://github.com/keiserlab/plaquebox-
paper/.
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